We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Updated: 3/16/2016
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/16/2016
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Updated: 3/16/2016
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Pioglitazone for the Treatment of Bipolar Depression
Updated: 3/16/2016
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated: 3/16/2016
Pioglitazone for the Treatment of Bipolar Depression
Updated: 3/16/2016
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
Updated: 3/16/2016
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
Status: Enrolling
Updated: 3/16/2016
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
Updated: 3/16/2016
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
A Study to Evaluate Abuse Potential of Istradefylline
Updated: 3/16/2016
A Double-Blind, Randomized, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Istradefylline in Recreational Drug Users
Status: Enrolling
Updated: 3/16/2016
A Study to Evaluate Abuse Potential of Istradefylline
Updated: 3/16/2016
A Double-Blind, Randomized, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Istradefylline in Recreational Drug Users
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Adaptation Processes in School-based Substance Abuse Prevention
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Status: Enrolling
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Adaptation Processes in School-based Substance Abuse Prevention
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Status: Enrolling
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Updated: 3/16/2016
Adaptation Processes in School-based Substance Abuse Prevention
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Aripiprazole Effects on Alcohol Drinking and Craving
Updated: 3/17/2016
Impulsivity and Drinking/Craving: Effect of a Dopamine Stabilizer Medication
Status: Enrolling
Updated: 3/17/2016
Aripiprazole Effects on Alcohol Drinking and Craving
Updated: 3/17/2016
Impulsivity and Drinking/Craving: Effect of a Dopamine Stabilizer Medication
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Kuvan in People With Schizophrenia and Schizoaffective Disorder
Updated: 3/17/2016
6R-BH 4 in People With Schizophrenia and Schizoaffective Disorder
Status: Enrolling
Updated: 3/17/2016
Kuvan in People With Schizophrenia and Schizoaffective Disorder
Updated: 3/17/2016
6R-BH 4 in People With Schizophrenia and Schizoaffective Disorder
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Risperdal Consta for Bipolar Disorder
Updated: 3/17/2016
A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence
Updated: 3/18/2016
Modification of Cognitive Processing Therapy (CPT-C) for Posttraumatic Stress Disorder (PTSD) and Alcohol Dependence (AD)
Status: Enrolling
Updated: 3/18/2016
Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence
Updated: 3/18/2016
Modification of Cognitive Processing Therapy (CPT-C) for Posttraumatic Stress Disorder (PTSD) and Alcohol Dependence (AD)
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
Updated: 3/18/2016
The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
Status: Enrolling
Updated: 3/18/2016
Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
Updated: 3/18/2016
The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Status: Enrolling
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Acupressure and Acupuncture as an Intervention With Children With Autism II
Updated: 3/21/2016
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated: 3/21/2016
Acupressure and Acupuncture as an Intervention With Children With Autism II
Updated: 3/21/2016
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 3/23/2016
An Eight-Week, Open Trial Pilot Investigation of Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/23/2016
Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 3/23/2016
An Eight-Week, Open Trial Pilot Investigation of Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Stress and Eating Study
Updated: 3/23/2016
Acceptance-based Group Intervention for Binge Eating
Status: Enrolling
Updated: 3/23/2016
Stress and Eating Study
Updated: 3/23/2016
Acceptance-based Group Intervention for Binge Eating
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Preventing Alcohol Withdrawal With Oral Baclofen
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen: A Randomized, Placebo Controlled Trial
Status: Enrolling
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen: A Randomized, Placebo Controlled Trial
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Preventing Alcohol Withdrawal With Oral Baclofen
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen: A Randomized, Placebo Controlled Trial
Status: Enrolling
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen
Updated: 3/23/2016
Preventing Alcohol Withdrawal With Oral Baclofen: A Randomized, Placebo Controlled Trial
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Updated: 3/23/2016
Computerized Stage-Matched Intervention for Juvenile Offenders
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Attention Training for Childhood Obsessive Compulsive Disorder
Updated: 3/23/2016
Attention Training for Childhood Obsessive Compulsive Disorder
Status: Enrolling
Updated: 3/23/2016
Attention Training for Childhood Obsessive Compulsive Disorder
Updated: 3/23/2016
Attention Training for Childhood Obsessive Compulsive Disorder
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Promoting Sleep to Prevent Substance Use in Adolescence
Updated: 3/23/2016
Promoting Sleep to Prevent Substance Use in Adolescence
Status: Enrolling
Updated: 3/23/2016
Promoting Sleep to Prevent Substance Use in Adolescence
Updated: 3/23/2016
Promoting Sleep to Prevent Substance Use in Adolescence
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values
Status: Enrolling
Updated: 3/23/2016
Updated: 3/23/2016
Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values
Status: Enrolling
Updated: 3/23/2016
Updated: 3/23/2016
Click here to add this to my saved trials
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Status: Enrolling
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Status: Enrolling
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Updated: 3/24/2016
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
Updated: 3/25/2016
The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/25/2016
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
Updated: 3/25/2016
The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
WHC+ (Women's Health CoOp PLUS)
Updated: 3/25/2016
Combination Prevention for Vulnerable Women in South Africa
Status: Enrolling
Updated: 3/25/2016
WHC+ (Women's Health CoOp PLUS)
Updated: 3/25/2016
Combination Prevention for Vulnerable Women in South Africa
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
WHC+ (Women's Health CoOp PLUS)
Updated: 3/25/2016
Combination Prevention for Vulnerable Women in South Africa
Status: Enrolling
Updated: 3/25/2016
WHC+ (Women's Health CoOp PLUS)
Updated: 3/25/2016
Combination Prevention for Vulnerable Women in South Africa
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
Updated: 3/25/2016
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
Status: Enrolling
Updated: 3/25/2016
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
Updated: 3/25/2016
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Updated: 3/28/2016
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Cognitive Intervention For Delirium in Dementia
Updated: 3/28/2016
Reserve For Delirium Superimposed On Dementia (DSD)
Status: Enrolling
Updated: 3/28/2016
Cognitive Intervention For Delirium in Dementia
Updated: 3/28/2016
Reserve For Delirium Superimposed On Dementia (DSD)
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Cognitive Intervention For Delirium in Dementia
Updated: 3/28/2016
Reserve For Delirium Superimposed On Dementia (DSD)
Status: Enrolling
Updated: 3/28/2016
Cognitive Intervention For Delirium in Dementia
Updated: 3/28/2016
Reserve For Delirium Superimposed On Dementia (DSD)
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials